People · Operator
Named in public records as an officer, director or promoter · active 2009–2026 · Biotechnology, Other, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| KALA BIO, Inc. | — | Biotechnology | Series C | $158.8M | $8.3M | 2026 |
| Cyclacel Pharmaceuticals, Inc. | — | Biotechnology | Series B | $61.3M | $5.2M | 2025 |
| LQR House Inc. | — | Other | Seed | $9.5M | $11.3M | 2024 |
| IR-Med, Inc. | — | Other Health Care | Seed | $5.4M | $36.9M | 2020 |
| Little Night Music Revival Co Limited Partnership | — | Other | Series A | $4.8M | $72.6M | 2009 |
DAVID LAZAR at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside DAVID LAZAR on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Kevin Bitterman | 1 | 15 |
| MARC ROUTH | 1 | 14 |
| David Babani | 1 | 10 |
| RICHARD FRANKEL | 1 | 10 |
| STEVEN BARUCH | 1 | 9 |
| Robert Spiegel | 1 | 8 |
| THOMAS VIERTEL | 1 | 8 |
| Robert Tepper | 1 | 7 |
| Yoram Drucker | 1 | 6 |
| Ron Mayron | 1 | 6 |
| Brian Schwartz | 1 | 6 |
| James O'Brien | 1 | 5 |
| Peter Simeon | 1 | 5 |
| Darren Collins | 1 | 5 |
| Andrew I. Koven | 1 | 4 |
| Eric L. Trachtenberg | 1 | 4 |
| PETER COUROSSI | 1 | 4 |
| DANIEL K. SPIEGELMAN | 1 | 4 |
| ROBERT PAULL | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.